Genetically modified T cell
Genetically modified TCR therapy is based on altering the specificity of T cells by expressing specific TCR α and β chains, which mediate antigen recognition. The tumor-specific TCR α and β chains were recognized, isolated and cloned into the transduction vector, and the transduction of T cells produced tumor antigen-specific T cells.
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian